WESTWOOD MANAGEMENT CORP /IL/ - PROGENICS PHARMACEUTICALS IN ownership

PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 155 filers reported holding PROGENICS PHARMACEUTICALS IN in Q1 2018. The put-call ratio across all filers is 0.92 and the average weighting 0.1%.

Quarter-by-quarter ownership
WESTWOOD MANAGEMENT CORP /IL/ ownership history of PROGENICS PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2018$96,000
+6.7%
12,0000.0%0.01%0.0%
Q1 2018$90,000
+26.8%
12,0000.0%0.01%
+30.0%
Q4 2017$71,000
-19.3%
12,0000.0%0.01%
-23.1%
Q3 2017$88,000
+8.6%
12,0000.0%0.01%0.0%
Q2 2017$81,000
-28.3%
12,0000.0%0.01%
-31.6%
Q1 2017$113,000
+8.7%
12,0000.0%0.02%
-5.0%
Q4 2016$104,000
-18.1%
12,000
-40.0%
0.02%
-13.0%
Q3 2016$127,00020,0000.02%
Other shareholders
PROGENICS PHARMACEUTICALS IN shareholders Q1 2018
NameSharesValueWeighting ↓
EVERENCE CAPITAL MANAGEMENT INC 28,980$123,0000.01%
Daiwa Securities Group Inc. 533$2,0000.00%
IFP Advisors, Inc 0$00.00%
NEW YORK STATE TEACHERS RETIREMENT SYSTEM 138,663$52,0000.00%
View complete list of PROGENICS PHARMACEUTICALS IN shareholders